Abstract
BackgroundThe majority of nonmuscle invasive bladder cancer (NMIBC) cases progress towards muscle invasive disease. Transurethral resection followed by chemotherapy and/or BCG immunotherapy can stall progression in the minority of NMIBC...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have